Literature DB >> 17522507

Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?

Pierre-A Clavien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17522507      PMCID： PMC1876968          DOI： 10.1097/SLA.0b013e31805d0788

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  26 in total

Review 1.  Surgical therapy of hepatocellular carcinoma.

Authors:  Lucas McCormack; Henrik Petrowsky; Pierre-Alain Clavien
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-05       Impact factor: 2.566

2.  Third forum on liver transplantation. Living donor liver transplantation. Who needs it? How to do it? Who should do it?

Authors:  Pierre-Alain Clavien
Journal:  J Hepatol       Date:  2005-07       Impact factor: 25.083

3.  Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.

Authors:  W Y Lau; T W Leung; S K Ho; M Chan; D Machin; J Lau; A T Chan; W Yeo; T S Mok; S C Yu; N W Leung; P J Johnson
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

4.  Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group.

Authors:  Y Muto; H Moriwaki; M Ninomiya; S Adachi; A Saito; K T Takasaki; T Tanaka; K Tsurumi; M Okuno; E Tomita; T Nakamura; T Kojima
Journal:  N Engl J Med       Date:  1996-06-13       Impact factor: 91.245

5.  Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data.

Authors:  Koji Takai; Masataka Okuno; Ichiro Yasuda; Rie Matsushima-Nishiwaki; Takahiro Uematsu; Hisashi Tsurumi; Yoshimune Shiratori; Yasutoshi Muto; Hisataka Moriwaki
Journal:  Intervirology       Date:  2005       Impact factor: 1.763

Review 6.  Prevention of hepatocellular carcinoma.

Authors:  Massimo Colombo; Maria Francesca Donato
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

7.  Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal.

Authors:  C C Wu; Y Z Ho; W L Ho; T C Wu; T J Liu; F K P'eng
Journal:  Br J Surg       Date:  1995-01       Impact factor: 6.939

Review 8.  Critical evaluation of the different staging systems for hepatocellular carcinoma.

Authors:  S Wildi; B C Pestalozzi; L McCormack; P-A Clavien
Journal:  Br J Surg       Date:  2004-04       Impact factor: 6.939

9.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

10.  A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma.

Authors:  S Yamasaki; H Hasegawa; H Kinoshita; M Furukawa; S Imaoka; K Takasaki; Y Kakumoto; H Saitsu; R Yamada; Y Oosaki; S Arii; E Okamoto; M Monden; M Ryu; S Kusano; T Kanematsu; K Ikeda; M Yamamoto; T Saoshiro; T Tsuzuki
Journal:  Jpn J Cancer Res       Date:  1996-02
View more
  12 in total

1.  Treatment Response After Unusual Low Dose Sorafenib: Diagnosis with Perfusion CT and Follow-up in a Patient with Recurrent Hepatocellular Carcinoma.

Authors:  Rodolfo Sacco; Lorenzo Faggioni; Irene Bargellini; Antonio Romano; Marco Bertini; Barbara Ginanni; Valentina Battaglia; Michele Bertoni; Elena Bozzi; Graziana Federici; Salvatore Metrangolo; Giuseppe Parisi; Emanuele Neri; Elisabetta Sodini; Emanuele Tumino; Giampaolo Bresci; Carlo Bartolozzi
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Interferon-γ induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1).

Authors:  Peiyuan Li; Qiang Du; Zongxian Cao; Zhong Guo; John Evankovich; Wei Yan; Ying Chang; Lifang Shao; Donna Beer Stolz; Allan Tsung; David A Geller
Journal:  Cancer Lett       Date:  2011-10-01       Impact factor: 8.679

3.  IFN-α facilitates the effect of sorafenib via shifting the M2-like polarization of TAM in hepatocellular carcinoma.

Authors:  Ze Zhang; Ying Zhu; Da Xu; Tian-En Li; Jian-Hua Li; Zi-Tian Xiao; Mo Chen; Xin Yang; Hu-Liang Jia; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

4.  Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis.

Authors:  Wei Zhang; Tian-Qiang Song; Ti Zhang; Qiang Wu; DA-Lu Kong; Qiang Li; Hui-Chuan Sun
Journal:  Mol Clin Oncol       Date:  2014-08-12

5.  Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.

Authors:  Asif A Dar; Trupti N Pradhan; Dakshayni P Kulkarni; Sagar U Shah; Kanury V Rao; Devendra A Chaukar; Anil K D'Cruz; Shubhada V Chiplunkar
Journal:  Immunology       Date:  2015-12-27       Impact factor: 7.397

6.  MicroRNA expression, survival, and response to interferon in liver cancer.

Authors:  Junfang Ji; Jiong Shi; Anuradha Budhu; Zhipeng Yu; Marshonna Forgues; Stephanie Roessler; Stefan Ambs; Yidong Chen; Paul S Meltzer; Carlo M Croce; Lun-Xiu Qin; Kwan Man; Chung-Mau Lo; Joyce Lee; Irene O L Ng; Jia Fan; Zhao-You Tang; Hui-Chuan Sun; Xin Wei Wang
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

Review 7.  Surgical treatment for hepatocellular carcinoma in cirrhotic patients. Guide to the selection and decision-making process in a context of multimodal strategy.

Authors:  H D González; J Figueras
Journal:  Clin Transl Oncol       Date:  2009-01       Impact factor: 3.405

Review 8.  Systemic therapy of hepatocellular carcinoma: current status and future perspectives.

Authors:  Domenico Germano; Bruno Daniele
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

9.  Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma.

Authors:  Ju-Bo Zhang; Hui-Chuan Sun; Wei-Dong Jia; Peng-Yuan Zhuang; Yong-Bing Qian; Xiao-Dong Zhu; Ling-Qun Kong; Lu Wang; Wei-Zhong Wu; Zhao-You Tang
Journal:  BMC Cancer       Date:  2012-10-01       Impact factor: 4.430

10.  Development of a miR-26 companion diagnostic test for adjuvant interferon-alpha therapy in hepatocellular carcinoma.

Authors:  Junfang Ji; Lei Yu; Zhipeng Yu; Marshonna Forgues; Takahiro Uenishi; Shoji Kubo; Kenichi Wakasa; Jian Zhou; Jia Fan; Zhao-You Tang; Shijun Fu; Hongguang Zhu; Jason Gang Jin; Hui-Chuan Sun; Xin Wei Wang
Journal:  Int J Biol Sci       Date:  2013-03-16       Impact factor: 6.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.